logo
  

GE Healthcare, SOPHiA GENETICS To Collaborate On Advancing Cancer Care

GE Healthcare and SOPHiA GENETICS said that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient's genomic profile and cancer type.

The companies aim to develop new artificial intelligence (AI)-powered analytics and workflow solutions to serve both the clinical and biopharma markets, GE said in a statement.

The companies will be deploying GE Healthcare's extensive medical imaging and monitoring capabilities and Edison platform-enabled data aggregation with the SOPHiA DDM cloud-based software-as-a-service analytics genomic insights platform and related solutions, which are available in more than 750 hospitals, laboratories and biopharma companies.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Target is set to make holiday shopping more easier than ever by providing customers additional functionalities to make pickups and deliveries extra convenient. Customers can now personalize their shopping experience by changing their needs and schedule to match changes in their plans. General Electric Company (GE) said it delivered a strong third quarter as orders grew, and margins continued to improve from a year ago. Adjusted GE Industrial organic profit increased 54% year-on-year, organically, driven primarily by increases at Aviation and Power, partially offset by decreases at... Ward Hill, Massachusetts-based Cedar's Mediterranean Foods is recalling Cedar's Organic Mediterranean Hommus citing undeclared pine nut, an allergen, the U.S. Food and Drug Administration said. The Cedar's Organic Mediterranean Hommus is packaged in a 10 oz. plastic container, with a UPC Code: 044115403028.
Follow RTT